Shopping Cart (0)
My Account

Your Shopping Cart
Nanomedicine 2013

Nanomedicine 2013



Welcome to Nanomedicine 2013 conference and exhibition. 

Market researchers have estimated that the Nanomedicine industry was worth over $72.8 billion in 2011 and is expected to grow rapidly to the level of influencing entire economies. Due to major advances in science and engineering, the relatively young field of nanotechnology has been expanding significantly. Despite the exciting advancements in this discipline, which involves miniscule manufactured products 1 – 100nm in size, the field of nanomedicine has yet to be exploited to its full potential. A large part of the nanomedicine industry is within the use of nanoparticles for the treatment of cancerous tumors. However, many nanoparticles show signs of toxicity in cells and this can be caused by the inherent properties, size and surface charge of the particles. This leaves the door open for engineered solutions to enable nanomedicine to continue progressing at its historic rate.

This conference will aim to provide a multidisciplinary approach to tackle the fundamental challenges in this speciality, innovative strategies for testing exposure, and techniques for improving the reliability and accuracy of results. 

The conference will be co-located with our ADME & Predictive Toxicology meeting. Registered delegates will have unrestricited access to both meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.


Keynote Speakers

Nadia Benkirane-Jessel

Nadia Benkirane-Jessel
Research Director, French National Institute of Health and Medical Research (Inserm)

Kattesh Katti

Kattesh Katti
Director, University of Missouri

Frederic Lagarce

Frederic Lagarce
Professor of Pharmaceutical Technology & Biopharmaceutics, Inserm, LUNAM University

Gunter Oberdorster

Gunter Oberdorster
Professor, University of Rochester

Agenda Topics

  • Connectivity between Traditional and Nanomedicine
  • Green Nanotechnology in Drug Discovery
  • Nanomedicine Approaches in Molecular Imaging
  • Nanomedicine in Theranostics
  • Nanoparticles and Nanomaterials in Therapy
  • Novel Synthetic Approaches in Nanomedicine
  • Regulatory Aspects Toward Approval of Nanomedicine Drugs
  • Toxicology Considerations in the Design and Development of Nanomedicine Formulations

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44(0)1787 315110

Confirmed Speakers to date

Andrei Gartel, Associate Professor, University of Illinois at Chicago
Paolo Ferruti, Professor, Universita di Milano
Carl Beckett, General Manager, Covaris Process Technologies
Arun Kumar, Assistant Professor, University of Delaware
Erem Bilensoy, Associate Professor, Hacettepe University Faculty of Pharmacy
Meenal Kowshick, Assistant Professor, Biral Institute of Technology and Sciences
Christine Dufes, Senior Lecturer in Drug Delivery, University of Strathclyde
Seamus Higson, Professor/Head, Cranfield University
Marie-Christine Jones, Lecturer, University of Birmingham
Maite Agueros Bazo, Postdoc Researcher, University of Navarra


Corporate Sponsors Media Sponsors Networking
U-Networks




There is currently no news for this conference.
    Keep me updated Select Bio Blog Linked in Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com